Login
$CLDX
$29.00 +$0.41 (1.43%) After hours

$CLDX SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
05 Nov 2026 S-3ASR
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

HAMPTON, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial results for the third quarter ended September 30, 2026 and provided a corporate update.

07 Oct 2026 SCHEDULE 13G/A
22 Sep 2026 8-K: Other Events

Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

14 Aug 2026 SCHEDULE 13G
14 Aug 2026 SCHEDULE 13G/A
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

HAMPTON, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial results for the second quarter ended June 30, 2026 and provided a corporate update.

15 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On July 10, 2026, Sam Martin, Senior Vice President and Chief Financial Officer of Celldex Therapeutics, Inc. (the “Company”), notified the Company of his plans to retire effective on or about March 31, 2027. Mr. Martin joined the Compan...

29 Jun 2026 Form 4: Lawver Teri L, SVP & Chief Commercial Officer

Granted 90,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Jimenez Freddy A., SVP & GENERAL COUNSEL

Granted 93,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Young Diane C., SVP, CHIEF MEDICAL OFFICER

Granted 57,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Heath-Chiozzi Margo, SVP OF REGULATORY AFFAIRS

Granted 95,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Martin Samuel Bates, SVP AND CFO

Granted 93,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Cavanaugh Sarah, SVP OF CORP AFFAIRS & ADMIN.

Granted 95,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Crowley Elizabeth, SR. VP & CPDO

Granted 100,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Pepin Ronald, SR. VP & CBO

Granted 20,000 Incentive Stock Option (right to buy)

29 Jun 2026 Form 4: Keler Tibor, EXECUTIVE VP & CSO

Granted 115,000 Incentive Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support